Industry: Medical Devices & Consumables
Published Date: 2024-11-22
Pages: 118 Pages
Report ld: 3382850
Request Sample
Customized Report
Bioabsorbable Eluting Coronary Stent System Market Size(US$)

CAGR 2024-2030
4.3%
Market Size,2030
USD 7,761
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Bioabsorbable Eluting Coronary Stent System was estimated to be worth US$ 5769 million in 2023 and is forecast to a readjusted size of US$ 7761 million by 2030 with a CAGR of 4.3% during the forecast period 2024-2030.
The bioresorbable eluting coronary stent system is a new type of coronary stent, made of degradable materials, which can be gradually absorbed by the human body after completing the tasks of vascular support and drug release, restoring the natural state of the blood vessels and reducing the risks of long-term implants. This stent is coated with a drug coating on the surface of the stent to slowly release drugs to inhibit vascular intimal hyperplasia and reduce the occurrence of restenosis.
North American market for Bioabsorbable Eluting Coronary Stent System was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Bioabsorbable Eluting Coronary Stent System was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Bioabsorbable Eluting Coronary Stent System was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Bioabsorbable Eluting Coronary Stent System include Boston Scientific, Medtronic, Abbott, B.Braun, BD, Biotronik AG, Stentys SA, Sino Medical, Beijing ESSEN Technology, Beijing Advanced Medical Technologies, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
This report aims to provide a comprehensive presentation of the global market for Bioabsorbable Eluting Coronary Stent System, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Bioabsorbable Eluting Coronary Stent System by region & country, by Type, and by Application.
The Bioabsorbable Eluting Coronary Stent System market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bioabsorbable Eluting Coronary Stent System.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Bioabsorbable Eluting Coronary Stent System manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Bioabsorbable Eluting Coronary Stent System in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Bioabsorbable Eluting Coronary Stent System in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Bioabsorbable Eluting Coronary Stent System Product Introduction
1.2 Global Bioabsorbable Eluting Coronary Stent System Market Size Forecast
1.2.1 Global Bioabsorbable Eluting Coronary Stent System Sales Value (2019-2030)
1.2.2 Global Bioabsorbable Eluting Coronary Stent System Sales Volume (2019-2030)
1.2.3 Global Bioabsorbable Eluting Coronary Stent System Sales Price (2019-2030)
1.3 Bioabsorbable Eluting Coronary Stent System Market Trends & Drivers
1.3.1 Bioabsorbable Eluting Coronary Stent System Industry Trends
1.3.2 Bioabsorbable Eluting Coronary Stent System Market Drivers & Opportunity
1.3.3 Bioabsorbable Eluting Coronary Stent System Market Challenges
1.3.4 Bioabsorbable Eluting Coronary Stent System Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Bioabsorbable Eluting Coronary Stent System Players Revenue Ranking (2023)
2.2 Global Bioabsorbable Eluting Coronary Stent System Revenue by Company (2019-2024)
2.3 Global Bioabsorbable Eluting Coronary Stent System Players Sales Volume Ranking (2023)
2.4 Global Bioabsorbable Eluting Coronary Stent System Sales Volume by Company Players (2019-2024)
2.5 Global Bioabsorbable Eluting Coronary Stent System Average Price by Company (2019-2024)
2.6 Key Manufacturers Bioabsorbable Eluting Coronary Stent System Manufacturing Base and Headquarters
2.7 Key Manufacturers Bioabsorbable Eluting Coronary Stent System Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Bioabsorbable Eluting Coronary Stent System
2.9 Bioabsorbable Eluting Coronary Stent System Market Competitive Analysis
2.9.1 Bioabsorbable Eluting Coronary Stent System Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Bioabsorbable Eluting Coronary Stent System Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bioabsorbable Eluting Coronary Stent System as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Rapamycin Eluting Stent
3.1.2 Everolimus Eluting Stent
3.1.3 Others
3.2 Global Bioabsorbable Eluting Coronary Stent System Sales Value by Type
3.2.1 Global Bioabsorbable Eluting Coronary Stent System Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Bioabsorbable Eluting Coronary Stent System Sales Value, by Type (2019-2030)
3.2.3 Global Bioabsorbable Eluting Coronary Stent System Sales Value, by Type (%) (2019-2030)
3.3 Global Bioabsorbable Eluting Coronary Stent System Sales Volume by Type
3.3.1 Global Bioabsorbable Eluting Coronary Stent System Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Bioabsorbable Eluting Coronary Stent System Sales Volume, by Type (2019-2030)
3.3.3 Global Bioabsorbable Eluting Coronary Stent System Sales Volume, by Type (%) (2019-2030)
3.4 Global Bioabsorbable Eluting Coronary Stent System Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospitals
4.1.2 Clinic
4.1.3 Others
4.2 Global Bioabsorbable Eluting Coronary Stent System Sales Value by Application
4.2.1 Global Bioabsorbable Eluting Coronary Stent System Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Bioabsorbable Eluting Coronary Stent System Sales Value, by Application (2019-2030)
4.2.3 Global Bioabsorbable Eluting Coronary Stent System Sales Value, by Application (%) (2019-2030)
4.3 Global Bioabsorbable Eluting Coronary Stent System Sales Volume by Application
4.3.1 Global Bioabsorbable Eluting Coronary Stent System Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Bioabsorbable Eluting Coronary Stent System Sales Volume, by Application (2019-2030)
4.3.3 Global Bioabsorbable Eluting Coronary Stent System Sales Volume, by Application (%) (2019-2030)
4.4 Global Bioabsorbable Eluting Coronary Stent System Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Bioabsorbable Eluting Coronary Stent System Sales Value by Region
5.1.1 Global Bioabsorbable Eluting Coronary Stent System Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Bioabsorbable Eluting Coronary Stent System Sales Value by Region (2019-2024)
5.1.3 Global Bioabsorbable Eluting Coronary Stent System Sales Value by Region (2025-2030)
5.1.4 Global Bioabsorbable Eluting Coronary Stent System Sales Value by Region (%), (2019-2030)
5.2 Global Bioabsorbable Eluting Coronary Stent System Sales Volume by Region
5.2.1 Global Bioabsorbable Eluting Coronary Stent System Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Bioabsorbable Eluting Coronary Stent System Sales Volume by Region (2019-2024)
5.2.3 Global Bioabsorbable Eluting Coronary Stent System Sales Volume by Region (2025-2030)
5.2.4 Global Bioabsorbable Eluting Coronary Stent System Sales Volume by Region (%), (2019-2030)
5.3 Global Bioabsorbable Eluting Coronary Stent System Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Bioabsorbable Eluting Coronary Stent System Sales Value, 2019-2030
5.4.2 North America Bioabsorbable Eluting Coronary Stent System Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Bioabsorbable Eluting Coronary Stent System Sales Value, 2019-2030
5.5.2 Europe Bioabsorbable Eluting Coronary Stent System Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Bioabsorbable Eluting Coronary Stent System Sales Value, 2019-2030
5.6.2 Asia Pacific Bioabsorbable Eluting Coronary Stent System Sales Value by Region (%), 2023 VS 2030
5.7 South America
5.7.1 South America Bioabsorbable Eluting Coronary Stent System Sales Value, 2019-2030
5.7.2 South America Bioabsorbable Eluting Coronary Stent System Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Bioabsorbable Eluting Coronary Stent System Sales Value, 2019-2030
5.8.2 Middle East & Africa Bioabsorbable Eluting Coronary Stent System Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Bioabsorbable Eluting Coronary Stent System Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Bioabsorbable Eluting Coronary Stent System Sales Value
6.2.1 Key Countries/Regions Bioabsorbable Eluting Coronary Stent System Sales Value, 2019-2030
6.2.2 Key Countries/Regions Bioabsorbable Eluting Coronary Stent System Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Bioabsorbable Eluting Coronary Stent System Sales Value, 2019-2030
6.3.2 United States Bioabsorbable Eluting Coronary Stent System Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Bioabsorbable Eluting Coronary Stent System Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Bioabsorbable Eluting Coronary Stent System Sales Value, 2019-2030
6.4.2 Europe Bioabsorbable Eluting Coronary Stent System Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Bioabsorbable Eluting Coronary Stent System Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Bioabsorbable Eluting Coronary Stent System Sales Value, 2019-2030
6.5.2 China Bioabsorbable Eluting Coronary Stent System Sales Value by Type (%), 2023 VS 2030
6.5.3 China Bioabsorbable Eluting Coronary Stent System Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Bioabsorbable Eluting Coronary Stent System Sales Value, 2019-2030
6.6.2 Japan Bioabsorbable Eluting Coronary Stent System Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Bioabsorbable Eluting Coronary Stent System Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Bioabsorbable Eluting Coronary Stent System Sales Value, 2019-2030
6.7.2 South Korea Bioabsorbable Eluting Coronary Stent System Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Bioabsorbable Eluting Coronary Stent System Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Bioabsorbable Eluting Coronary Stent System Sales Value, 2019-2030
6.8.2 Southeast Asia Bioabsorbable Eluting Coronary Stent System Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Bioabsorbable Eluting Coronary Stent System Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Bioabsorbable Eluting Coronary Stent System Sales Value, 2019-2030
6.9.2 India Bioabsorbable Eluting Coronary Stent System Sales Value by Type (%), 2023 VS 2030
6.9.3 India Bioabsorbable Eluting Coronary Stent System Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Boston Scientific
7.1.1 Boston Scientific Company Information
7.1.2 Boston Scientific Introduction and Business Overview
7.1.3 Boston Scientific Bioabsorbable Eluting Coronary Stent System Sales, Revenue, Price and Gross Margin (2019-2024)
7.1.4 Boston Scientific Bioabsorbable Eluting Coronary Stent System Product Offerings
7.1.5 Boston Scientific Recent Development
7.2 Medtronic
7.2.1 Medtronic Company Information
7.2.2 Medtronic Introduction and Business Overview
7.2.3 Medtronic Bioabsorbable Eluting Coronary Stent System Sales, Revenue, Price and Gross Margin (2019-2024)
7.2.4 Medtronic Bioabsorbable Eluting Coronary Stent System Product Offerings
7.2.5 Medtronic Recent Development
7.3 Abbott
7.3.1 Abbott Company Information
7.3.2 Abbott Introduction and Business Overview
7.3.3 Abbott Bioabsorbable Eluting Coronary Stent System Sales, Revenue, Price and Gross Margin (2019-2024)
7.3.4 Abbott Bioabsorbable Eluting Coronary Stent System Product Offerings
7.3.5 Abbott Recent Development
7.4 B.Braun
7.4.1 B.Braun Company Information
7.4.2 B.Braun Introduction and Business Overview
7.4.3 B.Braun Bioabsorbable Eluting Coronary Stent System Sales, Revenue, Price and Gross Margin (2019-2024)
7.4.4 B.Braun Bioabsorbable Eluting Coronary Stent System Product Offerings
7.4.5 B.Braun Recent Development
7.5 BD
7.5.1 BD Company Information
7.5.2 BD Introduction and Business Overview
7.5.3 BD Bioabsorbable Eluting Coronary Stent System Sales, Revenue, Price and Gross Margin (2019-2024)
7.5.4 BD Bioabsorbable Eluting Coronary Stent System Product Offerings
7.5.5 BD Recent Development
7.6 Biotronik AG
7.6.1 Biotronik AG Company Information
7.6.2 Biotronik AG Introduction and Business Overview
7.6.3 Biotronik AG Bioabsorbable Eluting Coronary Stent System Sales, Revenue, Price and Gross Margin (2019-2024)
7.6.4 Biotronik AG Bioabsorbable Eluting Coronary Stent System Product Offerings
7.6.5 Biotronik AG Recent Development
7.7 Stentys SA
7.7.1 Stentys SA Company Information
7.7.2 Stentys SA Introduction and Business Overview
7.7.3 Stentys SA Bioabsorbable Eluting Coronary Stent System Sales, Revenue, Price and Gross Margin (2019-2024)
7.7.4 Stentys SA Bioabsorbable Eluting Coronary Stent System Product Offerings
7.7.5 Stentys SA Recent Development
7.8 Sino Medical
7.8.1 Sino Medical Company Information
7.8.2 Sino Medical Introduction and Business Overview
7.8.3 Sino Medical Bioabsorbable Eluting Coronary Stent System Sales, Revenue, Price and Gross Margin (2019-2024)
7.8.4 Sino Medical Bioabsorbable Eluting Coronary Stent System Product Offerings
7.8.5 Sino Medical Recent Development
7.9 Beijing ESSEN Technology
7.9.1 Beijing ESSEN Technology Company Information
7.9.2 Beijing ESSEN Technology Introduction and Business Overview
7.9.3 Beijing ESSEN Technology Bioabsorbable Eluting Coronary Stent System Sales, Revenue, Price and Gross Margin (2019-2024)
7.9.4 Beijing ESSEN Technology Bioabsorbable Eluting Coronary Stent System Product Offerings
7.9.5 Beijing ESSEN Technology Recent Development
7.10 Beijing Advanced Medical Technologies
7.10.1 Beijing Advanced Medical Technologies Company Information
7.10.2 Beijing Advanced Medical Technologies Introduction and Business Overview
7.10.3 Beijing Advanced Medical Technologies Bioabsorbable Eluting Coronary Stent System Sales, Revenue, Price and Gross Margin (2019-2024)
7.10.4 Beijing Advanced Medical Technologies Bioabsorbable Eluting Coronary Stent System Product Offerings
7.10.5 Beijing Advanced Medical Technologies Recent Development
7.11 LifeTech Scientific Corporation
7.11.1 LifeTech Scientific Corporation Company Information
7.11.2 LifeTech Scientific Corporation Introduction and Business Overview
7.11.3 LifeTech Scientific Corporation Bioabsorbable Eluting Coronary Stent System Sales, Revenue, Price and Gross Margin (2019-2024)
7.11.4 LifeTech Scientific Corporation Bioabsorbable Eluting Coronary Stent System Product Offerings
7.11.5 LifeTech Scientific Corporation Recent Development
7.12 MicroPort Scientific Corporation
7.12.1 MicroPort Scientific Corporation Company Information
7.12.2 MicroPort Scientific Corporation Introduction and Business Overview
7.12.3 MicroPort Scientific Corporation Bioabsorbable Eluting Coronary Stent System Sales, Revenue, Price and Gross Margin (2019-2024)
7.12.4 MicroPort Scientific Corporation Bioabsorbable Eluting Coronary Stent System Product Offerings
7.12.5 MicroPort Scientific Corporation Recent Development
7.13 Yilson Medical Technology
7.13.1 Yilson Medical Technology Company Information
7.13.2 Yilson Medical Technology Introduction and Business Overview
7.13.3 Yilson Medical Technology Bioabsorbable Eluting Coronary Stent System Sales, Revenue, Price and Gross Margin (2019-2024)
7.13.4 Yilson Medical Technology Bioabsorbable Eluting Coronary Stent System Product Offerings
7.13.5 Yilson Medical Technology Recent Development
7.14 Lepu Medical Technology
7.14.1 Lepu Medical Technology Company Information
7.14.2 Lepu Medical Technology Introduction and Business Overview
7.14.3 Lepu Medical Technology Bioabsorbable Eluting Coronary Stent System Sales, Revenue, Price and Gross Margin (2019-2024)
7.14.4 Lepu Medical Technology Bioabsorbable Eluting Coronary Stent System Product Offerings
7.14.5 Lepu Medical Technology Recent Development
7.15 Shandong Hua'an Biotechnology
7.15.1 Shandong Hua'an Biotechnology Company Information
7.15.2 Shandong Hua'an Biotechnology Introduction and Business Overview
7.15.3 Shandong Hua'an Biotechnology Bioabsorbable Eluting Coronary Stent System Sales, Revenue, Price and Gross Margin (2019-2024)
7.15.4 Shandong Hua'an Biotechnology Bioabsorbable Eluting Coronary Stent System Product Offerings
7.15.5 Shandong Hua'an Biotechnology Recent Development
8 Industry Chain Analysis
8.1 Bioabsorbable Eluting Coronary Stent System Industrial Chain
8.2 Bioabsorbable Eluting Coronary Stent System Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Bioabsorbable Eluting Coronary Stent System Sales Model
8.5.2 Sales Channel
8.5.3 Bioabsorbable Eluting Coronary Stent System Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Bioabsorbable Eluting Coronary Stent System market is projected to grow from US$ 6255 million in 2025 to US$ 8376 million by 2032, at a CAGR of 4.3% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-25
Pages: 170
USD 4900.00
(Single User License)
The global Bioabsorbable Eluting Coronary Stent System market size was US$ 6255 million in 2025 and is forecast to reach a readjusted size of US$ 8376 million by 2032 with a CAGR of 4.3% during the forecast period 2026-2032.
Published Date: 2026-03-25
Pages: 95
USD 4250.00
(Single User License)
The global Bioabsorbable Eluting Coronary Stent System market was valued at US$ 6255 million in 2025 and is anticipated to reach US$ 8376 million by 2032, at a CAGR of 4.3% from 2026 to 2032.
Published Date: 2026-01-08
Pages: 124
USD 2900.00
(Single User License)
The global market for Bioabsorbable Eluting Coronary Stent System was estimated to be worth US$ 6255 million in 2025 and is projected to reach US$ 8376 million, growing at a CAGR of 4.3% from 2026 to 2032.
Published Date: 2026-01-08
Pages: 118
USD 3950.00
(Single User License)
The global Bioabsorbable Eluting Coronary Stent System market size was US$ 6021 million in 2024 and is forecast to a readjusted size of US$ 8062 million by 2031 with a CAGR of 4.3% during the forecast period 2025-2031.
Published Date: 2025-08-01
Pages: 94
USD 4250.00
(Single User License)
The global Bioabsorbable Eluting Coronary Stent System market is projected to grow from US$ 6021 million in 2024 to US$ 8062 million by 2031, at a CAGR of 4.3% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-08-01
Pages: 162
USD 4900.00
(Single User License)
The global market for Bioabsorbable Eluting Coronary Stent System was estimated to be worth US$ 6021 million in 2024 and is forecast to a readjusted size of US$ 8062 million by 2031 with a CAGR of 4.3% during the forecast period 2025-2031.
Published Date: 2025-03-10
Pages: 120
USD 3950.00
(Single User License)
The global market for Bioabsorbable Eluting Coronary Stent System was valued at US$ 6021 million in the year 2024 and is projected to reach a revised size of US$ 8062 million by 2031, growing at a CAGR of 4.3% during the forecast period.
Published Date: 2025-03-10
Pages: 93
USD 2900.00
(Single User License)
The bioresorbable eluting coronary stent system is a new type of coronary stent, made of degradable materials, which can be gradually absorbed by the human body after completing the tasks of vascular support and drug release, restoring the natural state of the blood vessels and reducing the risks of long-term implants. This stent is coated with a drug coating on the surface of the stent to slowly release drugs to inhibit vascular intimal hyperplasia and reduce the occurrence of restenosis.
Published Date: 2024-12-14
Pages: 136
USD 4350.00
(Single User License)
Valued at US$ 6021 million in 2024, the global Bioabsorbable Eluting Coronary Stent System market is forecast to reach US$ 7761 million by 2030, at a CAGR of 4.3% during the forecast period.
Published Date: 2024-11-22
Pages: 154
USD 4900.00
(Single User License)
The global Bioabsorbable Eluting Coronary Stent System market is projected to grow from US$ 6255 million in 2025 to US$ 8376 million by 2032, at a CAGR of 4.3% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-25
Pages: 170
The global Bioabsorbable Eluting Coronary Stent System market size was US$ 6255 million in 2025 and is forecast to reach a readjusted size of US$ 8376 million by 2032 with a CAGR of 4.3% during the forecast period 2026-2032.
Published: 2026-03-25
Pages: 95
The global Bioabsorbable Eluting Coronary Stent System market was valued at US$ 6255 million in 2025 and is anticipated to reach US$ 8376 million by 2032, at a CAGR of 4.3% from 2026 to 2032.
Published: 2026-01-08
Pages: 124
The global market for Bioabsorbable Eluting Coronary Stent System was estimated to be worth US$ 6255 million in 2025 and is projected to reach US$ 8376 million, growing at a CAGR of 4.3% from 2026 to 2032.
Published: 2026-01-08
Pages: 118
The global Bioabsorbable Eluting Coronary Stent System market size was US$ 6021 million in 2024 and is forecast to a readjusted size of US$ 8062 million by 2031 with a CAGR of 4.3% during the forecast period 2025-2031.
Published: 2025-08-01
Pages: 94
The global Bioabsorbable Eluting Coronary Stent System market is projected to grow from US$ 6021 million in 2024 to US$ 8062 million by 2031, at a CAGR of 4.3% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-08-01
Pages: 162
The global market for Bioabsorbable Eluting Coronary Stent System was estimated to be worth US$ 6021 million in 2024 and is forecast to a readjusted size of US$ 8062 million by 2031 with a CAGR of 4.3% during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 120
The global market for Bioabsorbable Eluting Coronary Stent System was valued at US$ 6021 million in the year 2024 and is projected to reach a revised size of US$ 8062 million by 2031, growing at a CAGR of 4.3% during the forecast period.
Published: 2025-03-10
Pages: 93
The bioresorbable eluting coronary stent system is a new type of coronary stent, made of degradable materials, which can be gradually absorbed by the human body after completing the tasks of vascular support and drug release, restoring the natural state of the blood vessels and reducing the risks of long-term implants. This stent is coated with a drug coating on the surface of the stent to slowly release drugs to inhibit vascular intimal hyperplasia and reduce the occurrence of restenosis.
Published: 2024-12-14
Pages: 136
Valued at US$ 6021 million in 2024, the global Bioabsorbable Eluting Coronary Stent System market is forecast to reach US$ 7761 million by 2030, at a CAGR of 4.3% during the forecast period.
Published: 2024-11-22
Pages: 154
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now